DRNA insider filings
Dicerna Pharmaceuticals Inc — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-12-29. Screen DRNA transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for DRNA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Dicerna Pharmaceuticals Inc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2021-12-29 | 4 | Zeng Ling — Chief Legal Officer & Sec'y | Code (U): 5,032 @ $38.25 · Disposition to issuer (D): 7,688 (derivative) · Disposition to issuer (D): 13,669 (derivative) · Disposition to issuer (D): 81,825 (derivative) · Disposition to issuer (D): 46,120 (derivative) | EDGAR |
| 2021-12-29 | 4 | Weissman James B — Chief Operating Officer & EVP | Code (U): 18,100 @ $38.25 · Disposition to issuer (D): 25,950 (derivative) · Disposition to issuer (D): 11,325 (derivative) · Disposition to issuer (D): 11,879 (derivative) · Disposition to issuer (D): 33,999 (derivative) · Disposition to issuer (D): 105,000 (derivative) · +5 more | EDGAR |
| 2021-12-29 | 4 | Smith Cynthia — Director | Code (U): 3,333 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) | EDGAR |
| 2021-12-29 | 4 | Pagan Douglas W. — Chief Financial Officer | Code (U): 7,775 @ $38.25 · Disposition to issuer (D): 20,475 (derivative) · Disposition to issuer (D): 6,150 (derivative) · Disposition to issuer (D): 95,650 (derivative) · Disposition to issuer (D): 36,900 (derivative) | EDGAR |
| 2021-12-29 | 4 | GRAY PATRICK M. — Director | Code (U): 3,333 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) | EDGAR |
| 2021-12-29 | 4 | Freed Martin I — Director | Code (U): 3,333 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · +2 more | EDGAR |
| 2021-12-29 | 4 | Doberstein Stephen K — Director | Code (U): 3,333 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) | EDGAR |
| 2021-12-29 | 4 | Ciappenelli Robert D. — Chief Strategy Officer | Code (U): 14,813 @ $38.25 · Disposition to issuer (D): 10,275 (derivative) · Disposition to issuer (D): 17,325 (derivative) · Disposition to issuer (D): 270,000 (derivative) · Disposition to issuer (D): 76,144 (derivative) · Disposition to issuer (D): 61,500 (derivative) | EDGAR |
| 2021-12-29 | 4 | Brown Bob D — Chief Scientific Ofr., EVP R&D | Code (U): 2,367 @ $38.25 · Disposition to issuer (D): 25,950 (derivative) · Disposition to issuer (D): 11,325 (derivative) · Disposition to issuer (D): 85,000 (derivative) · Disposition to issuer (D): 105,000 (derivative) · Disposition to issuer (D): 180,000 (derivative) · +4 more | EDGAR |
| 2021-12-29 | 4 | Aradhye Shreeram — EVP & Chief Medical Officer | Code (U): 6,973 @ $38.25 · Disposition to issuer (D): 21,075 (derivative) · Disposition to issuer (D): 8,513 (derivative) · Disposition to issuer (D): 124,700 (derivative) · Disposition to issuer (D): 51,070 (derivative) | EDGAR |
| 2021-12-29 | 4 | Koppel Adam — Director | Code (U): 3,333 @ $38.25 · Code (U): 3,080,237 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · +3 more | EDGAR |
| 2021-12-29 | 4 | FAMBROUGH DOUGLAS — Chief Executive Officer, Director | Disposition to issuer (D): 231,431 @ $38.25 · Disposition to issuer (D): 59,850 (derivative) · Disposition to issuer (D): 41,250 (derivative) · Disposition to issuer (D): 191,330 (derivative) · Disposition to issuer (D): 281,250 (derivative) · Disposition to issuer (D): 55,055 (derivative) · +9 more | EDGAR |
| 2021-12-29 | 4 | KOZIN MARC D — Director | Disposition to issuer (D): 6,333 @ $38.25 · Disposition to issuer (D): 5,000 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · +1 more | EDGAR |
| 2021-12-29 | 4 | BUCHI J KEVIN — Director | Code (U): 4,666 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 33,000 (derivative) · Disposition to issuer (D): 21,000 (derivative) · +1 more | EDGAR |
| 2021-12-29 | 4 | HOFFMAN STEPHEN J — Director | Code (U): 16,157 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · +5 more | EDGAR |
| 2021-12-17 | 4 | Pagan Douglas W. — Chief Financial Officer | Option exercise (M): 2,050 · Tax withholding (F): 602 @ $38.05 · Option exercise (M): 2,050 (derivative) @ $0 | EDGAR |
| 2021-12-17 | 4 | Ciappenelli Robert D. — Chief Strategy Officer | Option exercise (M): 3,425 · Tax withholding (F): 1,241 @ $38.05 · Option exercise (M): 3,425 (derivative) @ $0 | EDGAR |
| 2021-12-17 | 4 | Aradhye Shreeram — EVP & Chief Medical Officer | Option exercise (M): 2,837 · Tax withholding (F): 833 @ $38.05 · Option exercise (M): 2,837 (derivative) @ $0 | EDGAR |
| 2021-12-17 | 4 | Weissman James B — Chief Operating Officer & EVP | Option exercise (M): 3,775 · Tax withholding (F): 1,675 @ $38.05 · Option exercise (M): 3,775 (derivative) @ $0 | EDGAR |
| 2021-12-17 | 4 | Brown Bob D — Chief Scientific Ofr., EVP R&D | Option exercise (M): 3,775 · Tax withholding (F): 1,675 @ $38.05 · Option exercise (M): 3,775 (derivative) @ $0 | EDGAR |
| 2021-12-17 | 4 | Zeng Ling — Chief Legal Officer & Sec'y | Option exercise (M): 2,562 · Tax withholding (F): 752 @ $38.05 · Option exercise (M): 2,562 (derivative) @ $0 | EDGAR |
| 2021-12-17 | 4 | FAMBROUGH DOUGLAS — Chief Executive Officer, Director | Option exercise (M): 13,750 · Tax withholding (F): 5,348 @ $38.05 · Option exercise (M): 13,750 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | Ciappenelli Robert D. — Chief Strategy Officer | Option exercise (M): 8,856 @ $22.58 · Option exercise (M): 8,856 (derivative) @ $0 | EDGAR |
| 2021-12-13 | 4 | FAMBROUGH DOUGLAS — Chief Executive Officer, Director | Option exercise (M): 33,670 @ $2.97 · Option exercise (M): 146,195 @ $3.42 · Option exercise (M): 33,670 (derivative) @ $0 · Option exercise (M): 146,195 (derivative) @ $0 | EDGAR |
| 2021-11-22 | 4 | Brown Bob D — Chief Scientific Ofr., EVP R&D | Option exercise (M): 24,936 @ $3.42 · Sale (S): 24,936 @ $37.94 · Option exercise (M): 24,936 (derivative) @ $0 | EDGAR |
| 2021-09-21 | 4 | Brown Bob D — Chief Scientific Ofr., EVP R&D | Sale (S): 21,250 @ $21.06 | EDGAR |
| 2021-09-17 | 4 | Zeng Ling — Chief Legal Officer & Sec'y | Option exercise (M): 4,556 · Sale (S): 1,334 @ $21.47 · Option exercise (M): 4,556 (derivative) @ $0 | EDGAR |
| 2021-09-17 | 4 | Aradhye Shreeram — EVP & Chief Medical Officer | Option exercise (M): 7,025 · Sale (S): 2,056 @ $21.47 · Option exercise (M): 7,025 (derivative) @ $0 | EDGAR |
| 2021-08-10 | 4 | FAMBROUGH DOUGLAS — President and CEO, Director | Purchase (P): 5,000 @ $22.10 | EDGAR |
| 2021-08-10 | 4 | KOZIN MARC D — Director | Purchase (P): 3,000 @ $23.66 | EDGAR |
| 2021-08-03 | 4 | Brown Bob D — Chief Scientific Ofr., EVP R&D | Option exercise (M): 8,312 @ $3.42 · Sale (S): 8,312 @ $37.38 · Option exercise (M): 8,312 (derivative) @ $0 | EDGAR |
| 2021-07-08 | 4 | Paglia Regina M. — Chief Human Resources Officer | Option exercise (M): 1,450 · Option exercise (M): 1,712 · Tax withholding (F): 1,404 @ $37.05 · Option exercise (M): 1,450 (derivative) @ $0 · Option exercise (M): 1,712 (derivative) @ $0 | EDGAR |
| 2021-07-08 | 4 | Weissman James B — Chief Operating Officer & EVP | Option exercise (M): 30,000 @ $9.09 · Sale (S): 30,000 @ $39.09 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2021-07-06 | 4 | Brown Bob D — Chief Scientific Ofr., EVP R&D | Option exercise (M): 8,312 @ $3.42 · Sale (S): 7,246 @ $37.30 · Sale (S): 1,066 @ $37.85 · Option exercise (M): 8,312 (derivative) @ $0 | EDGAR |
| 2021-06-29 | 4 | Paglia Regina M. — Chief Human Resources Officer | Option exercise (M): 1,000 @ $22.58 · Sale (S): 1,000 @ $38.00 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2021-06-24 | 4 | Paglia Regina M. — Chief Human Resources Officer | Option exercise (M): 13,750 @ $12.93 · Option exercise (M): 2,279 @ $22.58 · Option exercise (M): 2,406 @ $24.05 · Sale (S): 13,555 @ $37.10 · Sale (S): 4,880 @ $36.71 · Option exercise (M): 13,750 (derivative) @ $0 · +2 more | EDGAR |
| 2021-06-22 | 4 | Paglia Regina M. — Chief Human Resources Officer | Option exercise (M): 4,664 @ $12.93 · Option exercise (M): 4,000 @ $24.05 · Sale (S): 8,664 @ $35.79 · Option exercise (M): 4,664 (derivative) @ $0 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Pagan Douglas W. — Chief Financial Officer | Option exercise (M): 6,825 · Tax withholding (F): 2,004 @ $35.74 · Option exercise (M): 6,825 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Paglia Regina M. — Chief Human Resources Officer | Option exercise (M): 381 · Tax withholding (F): 112 @ $35.74 · Option exercise (M): 20,000 @ $12.93 · Option exercise (M): 10,000 @ $22.58 · Option exercise (M): 1,564 @ $26.62 · Sale (S): 31,464 @ $35.63 · +5 more | EDGAR |
| 2021-06-15 | 4 | Brown Bob D — Chief Scientific Ofr., EVP R&D | Option exercise (M): 10,000 @ $9.09 · Sale (S): 10,000 @ $34 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2021-06-15 | 4 | Ciappenelli Robert D. — Chief Commercial Officer | Option exercise (M): 10,000 @ $15.61 · Sale (S): 10,000 @ $35 · Option exercise (M): 20,000 @ $15.61 · Sale (S): 20,000 @ $38 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2021-06-08 | 4 | Brown Bob D — Chief Scientific Ofr., EVP R&D | Option exercise (M): 10,000 @ $9.09 · Sale (S): 10,000 @ $33 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2021-06-07 | 4 | Freed Martin I — Director | Option exercise (M): 3,333 · Option exercise (M): 3,333 (derivative) @ $0 · Grant/award (A): 3,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-06-07 | 4 | GRAY PATRICK M. — Director | Option exercise (M): 3,333 · Option exercise (M): 3,333 (derivative) @ $0 · Grant/award (A): 3,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-06-07 | 4 | Doberstein Stephen K — Director | Option exercise (M): 3,333 · Option exercise (M): 3,333 (derivative) @ $0 · Grant/award (A): 3,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-06-07 | 4 | Koppel Adam — Director | Option exercise (M): 3,333 @ $0 · Option exercise (M): 3,333 (derivative) @ $0 · Grant/award (A): 3,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-06-07 | 4 | Protopapas Anna — Director | Option exercise (M): 3,333 · Option exercise (M): 3,333 (derivative) @ $0 | EDGAR |
| 2021-06-07 | 4 | KOZIN MARC D — Director | Option exercise (M): 3,333 · Option exercise (M): 3,333 (derivative) @ $0 · Grant/award (A): 3,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-06-07 | 4 | BUCHI J KEVIN — Director | Option exercise (M): 4,666 · Option exercise (M): 4,666 (derivative) @ $0 · Grant/award (A): 3,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-06-07 | 4 | HOFFMAN STEPHEN J — Director | Option exercise (M): 3,333 · Option exercise (M): 3,333 (derivative) @ $0 · Grant/award (A): 3,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Dicerna Pharmaceuticals Inc
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2021-12-28 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-11-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-11-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-08-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-08-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-06-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-05-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-04-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-03-12 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-03-02 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=DRNA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs